Johan Wassélius1, Stig Larsson, Hans Jacobsson. 1. Department of Radiology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. johan.wasselius@karolinska.se
Abstract
OBJECTIVE: It has been shown that [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) can identify macrophage-rich high-risk atherosclerotic plaques in animal models as well as in patients with atherosclerotic plaques in the carotid arteries. The development of inflamed macrophage-rich plaques over time is not well known. This study was performed to determine the variability of such FDG-accumulating plaques between consecutive PET/CT examinations. METHODS: Twenty-eight patients who underwent two whole-body FDG-PET/CT examinations within 7 months for malignant diseases were re-evaluated for atherosclerotic lesions in major arterial segments. The plaques were identified as active, inactive, or mixed depending on their appearance on PET and CT. Every identified plaque was compared with that of the other examination to evaluate the time-to-time correlation. RESULTS: The time-to-time correlation was close to 100% for calcified inactive plaques and about 50% for FDG-accumulating active plaques, with a high consistency between all examined arterial segments in this material. CONCLUSIONS: A large proportion of FDG-accumulating plaques can be identified on consecutive FDG-PET/CT examinations within 7 months.
OBJECTIVE: It has been shown that [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) can identify macrophage-rich high-risk atherosclerotic plaques in animal models as well as in patients with atherosclerotic plaques in the carotid arteries. The development of inflamed macrophage-rich plaques over time is not well known. This study was performed to determine the variability of such FDG-accumulating plaques between consecutive PET/CT examinations. METHODS: Twenty-eight patients who underwent two whole-body FDG-PET/CT examinations within 7 months for malignant diseases were re-evaluated for atherosclerotic lesions in major arterial segments. The plaques were identified as active, inactive, or mixed depending on their appearance on PET and CT. Every identified plaque was compared with that of the other examination to evaluate the time-to-time correlation. RESULTS: The time-to-time correlation was close to 100% for calcified inactive plaques and about 50% for FDG-accumulating active plaques, with a high consistency between all examined arterial segments in this material. CONCLUSIONS: A large proportion of FDG-accumulating plaques can be identified on consecutive FDG-PET/CT examinations within 7 months.
Authors: Kevin E Yarasheski; Erin Laciny; E Turner Overton; Dominic N Reeds; Michael Harrod; Steven Baldwin; Victor G Dávila-Román Journal: J Inflamm (Lond) Date: 2012-06-22 Impact factor: 6.283
Authors: Karel-Jan D F Lensen; Alper M van Sijl; Alexandre E Voskuyl; Conny J van der Laken; Martijn W Heymans; Emile F I Comans; Mike T Nurmohamed; Yvo M Smulders; Ronald Boellaard Journal: PLoS One Date: 2017-08-11 Impact factor: 3.240
Authors: Myra S Cocker; Brian Mc Ardle; J David Spence; Cheemun Lum; Robert R Hammond; Deidre C Ongaro; Matthew A McDonald; Robert A Dekemp; Jean-Claude Tardif; Rob S B Beanlands Journal: J Nucl Cardiol Date: 2012-12 Impact factor: 5.952
Authors: Sune F Pedersen; Anne Mette F Hag; Thomas L Klausen; Rasmus S Ripa; Rasmus P Bodholdt; Andreas Kjaer Journal: Clin Physiol Funct Imaging Date: 2013-12-01 Impact factor: 2.273